Home LiteratureArticle Details
PMID: 1673343 Published · ppublish English Journal Article

Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophrenia.

Journal of neural transmission. General section ·Vol. 83 ·No. 1-2 ·1991-00-00 ·Pages 25-35

Hetey L, Schwitzkowsky R, Ott T, Barz H

Abstract

Post-mortem brain regions of schizophrenics were investigated in comparison to matched controls regarding synaptosomal K(+)-stimulated [3H]DA release and its modulation by DA autoreceptors. Brain specimens were cryopreserved in liquid nitrogen until release experiments; synaptosomes from brain pieces preincubated with dimethylsulfoxide have unchanged ability for [3H]DA release and its autoreceptor-mediated inhibition after cryo-preservation. Release data were individually corrected for post-mortem delay back to the zero-time state based on [3H]DA release alterations after in situ preservation of rat heads. In schizophrenia, the K(+)-stimulated [3H]DA release from superfused synaptosomes of the nucleus (n.) accumbens and n. caudatus was diminished significantly. Furthermore, functional supersensitivity of the modulatory DA autoreceptors could be demonstrated in these regions. The alterations demonstrated seem not to be due primarily to medication since in neuroleptic-free patients similar changes were shown.

MeSH Terms
Amygdala/metabolism Animals Antipsychotic Agents/pharmacology Caudate Nucleus/metabolism Cryopreservation Dopamine/metabolism Frontal Lobe/metabolism Male Nucleus Accumbens/metabolism Postmortem Changes Potassium/pharmacology Rats Rats, Inbred Strains Receptors, Dopamine/metabolism Schizophrenia/metabolism Secretory Rate/drug effects Synaptosomes/drug effects,metabolism
Chemicals
Antipsychotic Agents Receptors, Dopamine Potassium Dopamine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Hetey L
Institute of Pharmacology and Toxicology of Charité, Humboldt University Berlin, German Democratic Republic.
Schwitzkowsky R
Ott T
Barz H
References (16)
16 references, click to expand
  1. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    J Pharmacol Exp Ther. 1983 Sep;226(3):680-5 PMID: 6887008
  2. Characterization of synaptosomal dopamine release in rat and human brain after post-mortem storage and cryopreservation.
    Neurochem Int. 1989;15(3):349-54 PMID: 20504505
  3. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Science. 1986 Dec 19;234(4783):1558-63 PMID: 2878495
  4. Post-mortem stability of dopamine, glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material.
    J Neurochem. 1978 Jul;31(1):381-3 PMID: 671036
  5. No D2 receptor increase in PET study of schizophrenia.
    Arch Gen Psychiatry. 1987 Jul;44(7):671-2 PMID: 2955770
  6. Characterization of synaptosomal dopamine uptake in post-mortem brain regions of schizophrenics.
    Neurochem Pathol. 1987 Dec;7(3):221-32 PMID: 3453902
  7. Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake.
    J Neural Transm. 1987;68(3-4):289-301 PMID: 3559541
  8. Studies in postmortem dopamine uptake. II. Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia.
    J Neural Transm. 1987;68(3-4):303-13 PMID: 3559542
  9. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Eur J Pharmacol. 1982 Nov 5;85(1):23-7 PMID: 6818043
  10. Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats.
    Neuropharmacology. 1986 Oct;25(10):1103-9 PMID: 2878387
  11. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    J Pharmacol Exp Ther. 1984 Nov;231(2):343-54 PMID: 6149306
  12. Biological studies in schizophrenia.
    Schizophr Bull. 1987;13(1):77-111 PMID: 3602940
  13. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    J Pharmacol Exp Ther. 1983 Aug;226(2):558-64 PMID: 6875865
  14. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia.
    Nature. 1983 Oct 6-12;305(5934):527-9 PMID: 6621699
  15. Schizophrenia: some current neurochemical approaches.
    J Neurochem. 1983 Jul;41(1):12-21 PMID: 6345723
  16. Down-regulation of central dopamine receptors in schizophrenia.
    Am J Psychiatry. 1985 Nov;142(11):1334-7 PMID: 2865903
Article Info
Journal
Journal of neural transmission. General section
Abbr.
J Neural Transm Gen Sect
Published
1991-00-00
Pages
25-35
Language
English
Region
Austria
NLM ID
9002201
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com